AtriCure Inc (NAS:ATRC)
$ 22.46 -0.28 (-1.23%) Market Cap: 1.09 Bil Enterprise Value: 1.07 Bil PE Ratio: 0 PB Ratio: 2.38 GF Score: 72/100

AtriCure Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 17, 2023 / 05:30PM GMT
Release Date Price: $42.74 (+0.68%)
Mike Matson
Needham & Company - Moderator

Good afternoon. Thanks for joining us at the 22nd Annual Needham Healthcare Conference. I'm Mike Matson, and I lead the med-tech and diagnostics equity research team at Needham and Company. I'm pleased to introduce AtriCure's CEO, Mike Carrel; and CFO, Angie Wirick.

Instead of a standard presentation, we're going to do a fireside chat or Q&A session. If you have any questions you would like to ask, you can submit them electronically through the Needham website -- sorry, conference website, or feel free to email them to me at [email protected], and I'll do my best to fit them in.

Questions & Answers

Mike Matson
Needham & Company - Moderator

So with that, we're just going to move straight into the questions. I guess I'll start with one, just I don't know what you're able to really say about trends in the first quarter.

But given just the spotty procedure growth rates we've seen across the industry quarter to quarter, given staffing and COVID infections and respiratory

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot